NasdaqGM - Delayed Quote USD

Invivyd, Inc. (IVVD)

2.1500 +0.0800 (+3.86%)
At close: April 26 at 4:00 PM EDT
2.2100 +0.06 (+2.79%)
After hours: April 26 at 5:25 PM EDT
Currency in USD All numbers in thousands
Download
Breakdown
TTM
12/31/2023
12/31/2022
12/31/2021
Operating Expense
207,783.0000
207,783.0000
226,258.0000
219,408.0000
Operating Income
-207,783.0000
-207,783.0000
-226,258.0000
-219,408.0000
Other Income Expense
9,140.0000
9,140.0000
-15,059.0000
-7,382.0000
Pretax Income
-198,643.0000
-198,643.0000
-241,317.0000
-226,790.0000
Net Income Common Stockholders
-198,643.0000
-198,643.0000
-241,317.0000
-226,790.0000
Diluted NI Available to Com Stockholders
-198,643.0000
-198,643.0000
-241,317.0000
-226,790.0000
Basic EPS
-1.81
--
-2.23
-5.32
Diluted EPS
-1.81
--
-2.23
-5.32
Basic Average Shares
109,526.0530
--
108,268.2890
42,621.2650
Diluted Average Shares
109,526.0530
--
108,268.2890
42,621.2650
Total Operating Income as Reported
-212,758.0000
-212,758.0000
-248,031.0000
-226,908.0000
Total Expenses
207,783.0000
207,783.0000
226,258.0000
219,408.0000
Net Income from Continuing & Discontinued Operation
-198,643.0000
-198,643.0000
-241,317.0000
-226,790.0000
Normalized Income
-193,668.0000
-193,668.0000
-219,544.0000
-219,290.0000
EBIT
-207,783.0000
-207,783.0000
-226,258.0000
-219,408.0000
EBITDA
-205,755.0000
-205,755.0000
-225,796.0000
-219,407.0000
Reconciled Depreciation
2,028.0000
2,028.0000
462.0000
1.0000
Net Income from Continuing Operation Net Minority Interest
-198,643.0000
-198,643.0000
-241,317.0000
-226,790.0000
Total Unusual Items Excluding Goodwill
-4,975.0000
-4,975.0000
-21,773.0000
-7,500.0000
Total Unusual Items
-4,975.0000
-4,975.0000
-21,773.0000
-7,500.0000
Normalized EBITDA
-200,780.0000
-200,780.0000
-204,023.0000
-211,907.0000
12/31/2021 - 8/6/2021

Upgrade to begin using 40 years of financial statements and get so much more.

Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.

Upgrade

Related Tickers

RLYB Rallybio Corporation
1.7000
+3.03%
 
BTAI BioXcel Therapeutics, Inc.
2.6300
+0.77%
 
LCTX Lineage Cell Therapeutics, Inc.
1.1400
+2.70%
 
TRML Tourmaline Bio, Inc.
15.68
-2.00%
 
HOTH Hoth Therapeutics, Inc.
1.1600
0.00%
 
ETNB 89bio, Inc.
8.26
+0.12%
 
IMNN Imunon, Inc.
1.4400
0.00%
 
BYSI BeyondSpring Inc.
2.1300
-6.17%
 
GTHX G1 Therapeutics, Inc.
3.9900
+3.37%
 
ANTX AN2 Therapeutics, Inc.
2.3200
+1.75%